Clinical Trial Update: Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial update on long-term immunogenicity and safety of an HPV vaccine in healthy females with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection
• Papillomavirus Infections

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2011-05-02